UPDATE: Peregrine Pharma Reports Data on Bavituximab Presented at AACR Validates Immune-Stimulatory Mechanism of Action
April 09, 2014 at 11:05 AM EDT
Peregrine Pharmaceuticals (NASDAQ: PPHM) today announced data from studies validating the immune-stimulatory mechanism of action of ...